DMD Intelligence

David Reim, Chief Privacy Officer

David Reim, Chief Privacy Officer

David Reim, Chief Privacy Officer at DMD, has been a leader in the digital marketing of healthcare products since he led the team that launched the first branded pharmaceutical website in 1995. David oversees the commercialization of all DMD products, from the industry’s No. 1 physician email database to the Audience Identity Manager (AIM) platform, named by PM360 magazine as one of the leading innovations of 2017.

Author's Posts

Digital Pharma East 2018: 5 Sessions You Shouldn’t Miss

David Reim, Chief Privacy Officer

The Digital Pharma East conference is always high on my list of must-attend events. This year is no exception. The agenda is packed with more timely presentations than ever to select from, making it a particularly worthwhile trip.

With the growing intersection between online and offline channels, it’s becoming increasingly important for companies operating in the pharma and healthcare spaces to find a way to navigate. I am hopeful that some of the experts leading sessions will shine a light on possible paths to take moving forward.

Read More
Topics: Pharma Marketing

DMD Innovators Series: Allison Hartsoe, Ambition Data

David Reim, Chief Privacy Officer

Allison Hartsoe is the Founder and CEO of Ambition Data. Her experience and passion for analysis allow her to see future trends and relate them all the way back to the tactical moves her clients need to make today. She has built and executed digital analytics strategies for Fortune 500 customers including Blackrock, BlueShield, Genentech, GlaxoSmithKline, HP, Intel, Microsoft, Nike, and Seagate. She is also a member of the C-Suite Network.

Read More
Topics: Pharma Marketing, Pharma Innovator Series

DMD Pharma Innovators Series: Serge Loncar, CareSpeak

David Reim, Chief Privacy Officer

Serge Loncar started CareSpeak in 2011, guided by the belief that the mobile phone, as the most personal accessory, will play an increasingly important role in managing one's health. Prior to starting CareSpeak, Serge was the President of Songbird Hearing, the manufacturer and marketer of the first disposable over-the-counter hearing aid. Prior to that, he headed up strategic business development at cdnow.com, which was acquired by Bertelsmann AG. Serge also held numerous domestic and international brand marketing and sales positions at Johnson & Johnson health care and medical device divisions, and Pepsi Cola International in the USA and Europe. Serge received his MBA from New York University's Stern Business School after immigrating from Croatia.

For DMD’s Pharma Innovators Series, David Reim spoke with Serge Loncar, Founder and CEO of CareSpeak Communications, about the value in today’s marketplace of providing patients with an effortless way to manage their health using an advanced SMS platform like CareSpeak. This approach helps to achieve better outcomes by engaging patients and caregivers, improving medication compliance, and assisting with care coordination.

Read More
Topics: Precision Targeting, Pharma Innovator Series, Healthcare Marketing

The AdTech-MarTech Convergence: Making An Argument For Email’s Value

David Reim, Chief Privacy Officer

Healthcare marketers focused on developing engaging customer journeys understand email is a deterministic identifier, and can be used to link an individual’s digital activity across multiple channels. That is to say, the email address is positioned to be the unique identifier that can actually unify other digital marketing solutions.

Read More
Topics: Email Marketing, Healthcare Marketing

GDPR: Why DMD Is The Calm In The Storm

David Reim, Chief Privacy Officer

You’ve likely received an email or two (or twenty) referencing the European Union’s implementation of the General Data Protection Regulation (GDPR), which took effect May 25, 2018. While GDPR is an EU standard, it’s already had a global impact. Companies around the world—from large corporations to small firms—were tasked with deploying “repermissioning campaigns,” fearing the worst in terms of regulatory compliance.

All of this has created quite a digital windstorm surrounding privacy, compliance, and the protection of data. Instead of getting sucked up into the GDPR hurricane, take a minute to sit in the calm of the storm.

Read More
Topics: Email Marketing, Health Systems Marketing, Data Privacy

Product Launch Or New Indication: Email Offers Flexibility And Reach

David Reim, Chief Privacy Officer

In part 2 of our 4 part series, Leveraging the Email Channel Throughout the Pharma Brand Life Cycle, we consider how email marketing can be used to optimize the product launch and introduce a new indication.

The email channel plays a pivotal role throughout a pharma brand’s growth and maturation. This is never more critical than at launch, when the long-term success of the brand is at stake.

Read More
Topics: Physician Engagement, Pharma Marketing, Expanding HCP Reach

Market Development And Clinical Trials: Tell Your Product Story Early

David Reim, Chief Privacy Officer

In part 1 of our 4-part series, Leveraging the Email Channel Throughout the Pharma Brand Life Cycle, we explore the digital strategies that are most effective during market development and clinical trials.

Pharmaceutical companies have never had more riding on the successful launches of new drugs. According to research from Bain & Company, brands are expected to derive up to 80 percent of revenue from product launches by 2021. Yet nearly 50 percent of recent launches failed to meet analyst expectations.

Read More
Topics: Pharma Marketing

Office Or Personal: What’s The Best Email For Physician Outreach?

David Reim, Chief Privacy Officer

It goes without saying that the success of your pharma brand depends on physicians. Yet marketing to physicians is a balancing act. You need to engage them frequently enough to convey your product’s value and build strong relationships, but you don’t want to alienate them by sending unwanted email.

One of the best ways to avoid sending email that may be considered irrelevant is to understand and respect physician’s preferences regarding where they receive email.

Read More
Topics: Pharma Marketing

Learn Where HCPs Get Information Online At eyeforpharma 2018

David Reim, Chief Privacy Officer

Email marketing, brand websites, social media, paid advertising. Which is most effective for getting a physician’s attention? For building relationships? Or for delivering timely medical information?

Any way you slice it, channel selection presents a challenge for pharma marketers. At eyeforpharma, I’m going to ask you to step back from this problem long enough to consider the underlying question: How and where do your customers gain their information?

Read More
Topics: Pharma Marketing

Deliver The Content Physicians Need To Make Better Decisions Faster

David Reim, Chief Privacy Officer

In the current healthcare economy, maximizing value is the surest way to maximize commercial performance. It’s also the best way to improve patient outcomes. Eyeforpharma 2018 will explore how pharma companies are working to achieve both goals.

New data sourcing and analysis techniques play a critical role in this process. Though the first tools that come to mind might be patient-facing, physician data sources, like audience identity management technology, are equally important.

Read More
Topics: Pharma Marketing

Subscribe to Email Updates

About the Blog

DMD President Roger Korman and his management team publish weekly articles on digital communication and technology in healthcare.

Articles are published that cover website visitor identity, the value of authenticated healthcare professional databases for use in multichannel marketing to physicians and healthcare professionals. DMD clients in pharma, hospital and health systems, agencies, and physician marketing companies rely on DMD's email and AIMSM technologies to improve communication with healthcare professionals across marketing channels.